Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidal Essebag

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 28, 2020
Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trialsGirish M Nair, David H Birnie, Glen L Sumner, et al.
The Canadian Journal of Cardiology|July 9, 2009
Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory CommitteeAndrew D Krahn, Christopher S Simpson, Ratika Parkash, et al.
The Canadian Journal of Cardiology|August 5, 2019
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and DesignLena Rivard, Paul Khairy, Mario Talajic, et al.
Circulation. Arrhythmia and Electrophysiology|October 16, 2019
Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2Vidal Essebag, Jeff S Healey, Jacqueline Joza, et al.
The New England Journal of Medicine|November 10, 2025
Antithrombotic Therapy after Successful Catheter Ablation for Atrial FibrillationAtul Verma, David H Birnie, Chenyang Jiang, et al.
The New England Journal of Medicine|November 18, 2024
Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaJohn L Sapp, Anthony S L Tang, Ratika Parkash, et al.
The American Journal of Cardiology|July 2, 2017
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)Alexandra Silberberg, Mary K Tan, Andrew T Yan, et al.
The Canadian Journal of Cardiology|January 15, 2026
Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White PaperJacqueline Joza, Francois Philippon, Derek S Chew, et al.
Lancet (London, England)|August 27, 2023
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trialBruce L Wilkoff, Gerasimos Filippatos, Christophe Leclercq, et al.
Journal of the American College of Cardiology|December 7, 2019
Risk Factors for Infections Involving Cardiac Implanted Electronic DevicesDavid H Birnie, Jia Wang, Marco Alings, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 28, 2020
Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trialsGirish M Nair, David H Birnie, Glen L Sumner, et al.
The Canadian Journal of Cardiology|July 9, 2009
Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory CommitteeAndrew D Krahn, Christopher S Simpson, Ratika Parkash, et al.
The Canadian Journal of Cardiology|August 5, 2019
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and DesignLena Rivard, Paul Khairy, Mario Talajic, et al.
Circulation. Arrhythmia and Electrophysiology|October 16, 2019
Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2Vidal Essebag, Jeff S Healey, Jacqueline Joza, et al.
The New England Journal of Medicine|November 10, 2025
Antithrombotic Therapy after Successful Catheter Ablation for Atrial FibrillationAtul Verma, David H Birnie, Chenyang Jiang, et al.
The New England Journal of Medicine|November 18, 2024
Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaJohn L Sapp, Anthony S L Tang, Ratika Parkash, et al.
The American Journal of Cardiology|July 2, 2017
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)Alexandra Silberberg, Mary K Tan, Andrew T Yan, et al.
The Canadian Journal of Cardiology|January 15, 2026
Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White PaperJacqueline Joza, Francois Philippon, Derek S Chew, et al.
Lancet (London, England)|August 27, 2023
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trialBruce L Wilkoff, Gerasimos Filippatos, Christophe Leclercq, et al.
Journal of the American College of Cardiology|December 7, 2019
Risk Factors for Infections Involving Cardiac Implanted Electronic DevicesDavid H Birnie, Jia Wang, Marco Alings, et al.
Pageof 19